These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors. Jin G; Lee S; Choi M; Son S; Kim GW; Oh JW; Lee C; Lee K Eur J Med Chem; 2014 Mar; 75():413-25. PubMed ID: 24561671 [TBL] [Abstract][Full Text] [Related]
12. Discovery of novel pan-genotypic HCV NS5A inhibitors containing a novel tetracyclic core. Yu W; Hu B; Zhong B; Hao J; Lei Z; Agrawal S; Rokosz L; Liu R; Chen S; Asante-Appiah E; Kozlowski JA Bioorg Med Chem Lett; 2019 Mar; 29(5):700-706. PubMed ID: 30711390 [TBL] [Abstract][Full Text] [Related]
13. Alkyl substituted aminal derivatives of HCV NS5A inhibitor MK-8742. Yu W; Coburn CA; Nair AG; Wong M; Tong L; Dwyer MP; Hu B; Zhong B; Hao J; Yang DY; Selyutin O; Jiang Y; Rosenblum SB; Kim SH; Lavey BJ; Zhou G; Rizvi R; Shankar BB; Zeng Q; Chen L; Agrawal S; Carr D; Rokosz L; Liu R; Curry S; McMonagle P; Ingravallo P; Lahser F; Asante-Appiah E; Nomeir A; Kozlowski JA Bioorg Med Chem Lett; 2016 Aug; 26(15):3800-5. PubMed ID: 27282742 [TBL] [Abstract][Full Text] [Related]
14. Discovery of silyl proline containing HCV NS5A inhibitors with pan-genotype activity: SAR development. Nair AG; Zeng Q; Selyutin O; Rosenblum SB; Jiang Y; Yang DY; Keertikar K; Zhou G; Dwyer MP; Kim SH; Shankar B; Yu W; Tong L; Chen L; Mazzola R; Caldwell J; Tang H; Allard ML; Buckle RN; Gauuan PJ; Holst CL; Martin GS; Naicker KP; Vellekoop S; Agrawal S; Liu R; Kong R; Ingravallo P; Xia E; Zhai Y; Nomeir A; Kozlowski JA Bioorg Med Chem Lett; 2016 Mar; 26(5):1475-9. PubMed ID: 26850003 [TBL] [Abstract][Full Text] [Related]
15. MK-8325: A silyl proline-containing NS5A inhibitor with pan-genotype activity for treatment of HCV. Nair AG; Zeng Q; Selyutin O; Rosenblum SB; Jiang Y; Yang DY; Keertikar K; Zhou G; Dwyer M; Kim SH; Shankar B; Yu W; Tong L; Chen L; Mazzola R; Caldwell J; Tang H; Agrawal S; Liu R; Kong R; Ingravallo P; Xia E; Zhai Y; Nomeir A; Asante-Appiah E; Kozlowski JA Bioorg Med Chem Lett; 2018 Jun; 28(10):1954-1957. PubMed ID: 29653894 [TBL] [Abstract][Full Text] [Related]
16. Potent bisimidazole-based HCV NS5A inhibitors bearing annulated tricyclic motifs. Zhong M; Peng E; Huang N; Huang Q; Huq A; Lau M; Colonno R; Li L Bioorg Med Chem Lett; 2014 Dec; 24(24):5738-5742. PubMed ID: 25453811 [TBL] [Abstract][Full Text] [Related]
17. Discovery of ravidasvir (PPI-668) as a potent pan-genotypic HCV NS5A inhibitor. Zhong M; Peng E; Huang N; Huang Q; Huq A; Lau M; Colonno R; Li L Bioorg Med Chem Lett; 2016 Sep; 26(18):4508-4512. PubMed ID: 27506559 [TBL] [Abstract][Full Text] [Related]
18. Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Polymorphisms. Tong L; Yu W; Chen L; Selyutin O; Dwyer MP; Nair AG; Mazzola R; Kim JH; Sha D; Yin J; Ruck RT; Davies IW; Hu B; Zhong B; Hao J; Ji T; Zan S; Liu R; Agrawal S; Xia E; Curry S; McMonagle P; Bystol K; Lahser F; Carr D; Rokosz L; Ingravallo P; Chen S; Feng KI; Cartwright M; Asante-Appiah E; Kozlowski JA J Med Chem; 2017 Jan; 60(1):290-306. PubMed ID: 27808515 [TBL] [Abstract][Full Text] [Related]
19. Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication. Berger C; Romero-Brey I; Radujkovic D; Terreux R; Zayas M; Paul D; Harak C; Hoppe S; Gao M; Penin F; Lohmann V; Bartenschlager R Gastroenterology; 2014 Nov; 147(5):1094-105.e25. PubMed ID: 25046163 [TBL] [Abstract][Full Text] [Related]
20. HCV NS5A replication complex inhibitors. Part 5: discovery of potent and pan-genotypic glycinamide cap derivatives. Belema M; Nguyen VN; St Laurent DR; Lopez OD; Qiu Y; Good AC; Nower PT; Valera L; O'Boyle DR; Sun JH; Liu M; Fridell RA; Lemm JA; Gao M; Knipe JO; Meanwell NA; Snyder LB Bioorg Med Chem Lett; 2013 Aug; 23(15):4428-35. PubMed ID: 23803586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]